BYPASS ANGIOPLASTY REVASCULARIZATION INVESTIGATION 2 DIABETES (BARI 2D)

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 本试验旨在确定初始选择性冠状动脉血运重建联合积极药物治疗的疗效，以及在高血糖症管理中提供更多胰岛素与增加胰岛素敏感性的疗效。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This trial is designed to determine the efficacy of initial elective coronary revascularization combined with aggressive medical therapy, and the efficacy of providing more insulin vs. increasing sensitivity to insulin in the management of hyperglycemia.